Strategies to Address Chimeric Antigen Receptor Tonic Signaling

Abstract excerpt

Abstract Adoptive cell transfer using chimeric antigen receptors (CAR) has emerged as one of the most promising new therapeutic modalities for patients with relapsed or refractory B-cell malignancies. Thus far, results in patients with advanced solid tumors have proven disappointing. Constitutive tonic signaling in the absence of ligand is an increasingly recognized complication when deploying these synthetic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CAR-T cell therapy research